Neuroblastic Tumor — Trials

Neuroblastic Tumor — Trials · CancerIndex

Clinical trials

Registered studies

619 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 137
Recruiting: 75
Ph III recruiting: 8
Growth YoY: −28%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (80)

clinicaltrialsPublishedShowing 1–50 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06502210	Identification of New Gene Spliceosomes in Neuroblastoma	unknown	—	20	Affiliated Hospital of Nantong UniversityOTHER	1	Jul 16, 2024	clinicaltrials
NCT06275334	Dinutuximab Beta at the HUS and the Toulouse Oncopole(DNB)	unknown	—	40	University Hospital, Strasbourg, FranceOTHER	1	Feb 23, 2024